查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000826

復健機器人市場：2026-2032年全球市場預測（按產品類型、機器人設計、目標身體部位、應用和最終用戶分類）

Rehabilitation Robots Market by Product Type, Robot Design, Body Region, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，康復機器人市場價值將達到 5.7505 億美元，到 2026 年將成長到 6.7262 億美元，到 2032 年將達到 16.3419 億美元，複合年成長率為 16.09%。

主要市場統計數據
基準年 2025 5.7505億美元
預計年份：2026年 6.7262億美元
預測年份 2032 1,634,190,000 美元
複合年成長率 (%) 16.09%

簡要介紹康復機器人的現狀：重點關注臨床應用的促進因素、底層技術以及向可擴展的、以患者為中心的解決方案的轉變。

復健機器人技術融合了醫學、工程學和人性化的設計理念，從實驗室原型發展成為可用於臨床、增強治療效果的工具。過去十年間，復健機器人設備的設計已從僵硬的工業機械式結構轉變為更具適應性、配備豐富感測器的系統，更加注重患者的舒適度、功能恢復以及數據驅動的個人化治療。這項發展歷程反映了嵌入式感測器、執行器小型化、材料科學以及能夠解讀複雜運動模式的機器學習演算法等方面的同步進步。

概述推動復健機器人領域發展的關鍵變革，包括人工智慧整合、分散式護理和強大的商業化方法。

在復健機器人領域，多項變革正在發生，重塑產品設計、臨床應用模式和商務策略。首先，智慧技術的整合應用日益廣泛。嵌入式感測器、雲端分析和自適應控制演算法使設備能夠學習患者特定的運動模式，並即時調整輔助力度。這種能力提高了治療的個人化程度，並為追蹤長期療效創造了機會。

2025 年關稅環境如何重塑製造和採購中復健機器人的供應鏈、籌資策略和經營模式。

貿易政策和關稅結構的變化會對復健設備的製造商、零件供應商和下游買家產生重大影響。美國關稅於2025年生效，其累積效應已在多個業務領域顯現，包括零件採購、契約製造經濟效益和定價策略。依賴進口執行器、高精度感測器或特種聚合物的供應商正面臨投入成本上升的困境，迫使製造商重新評估其採購策略和產品架構選擇。

詳細的細分分析揭示了設備架構、治療應用和最終用戶環境如何共同決定臨床效用和商業化路徑。

細分市場層面的趨勢凸顯了臨床需求、設備功能和護理模式的交會點如何影響產品策略和商業化進程。按設備類型分類，範圍涵蓋末端執行器機器人和外骨骼機器人。末端執行器機器人分為固定式（固定在固定平台上）和穿戴式式，後者能夠實現更自然、更貼近任務的運動。每種設計方法都會影響臨床工作流程、便攜性和復原任務的針對性。外骨骼機器人分為全身型、下肢型和上肢型，這些差異導致驅動複雜性、控制方法和患者連接程序等方面的技術權衡有所不同。

深入分析人口趨勢、醫療保健資金籌措模式和法規環境如何影響全球主要市場的採用趨勢。

復健機器人技術的區域發展趨勢反映了人口壓力、醫療資金籌措模式和法規環境的差異。在美洲，人口老化、集中化的醫療網路和完善的報銷體系促進了機器人療法在住院和門診病人中的早期應用。該地區的醫療服務提供者越來越注重營運效率和長期復健效果，而私人保險公司和公共計畫則對報銷機制的設計產生影響。

這篇對企業策略的深刻分析表明，臨床證據、硬體和軟體整合以及服務主導的經營模式如何決定競爭優勢。

復健機器人領域的競爭格局由那些兼具臨床可靠性、卓越工程技術和市場反應的公司主導。主要企業正大力投資於臨床證據的積累，與大學附屬醫院和復健診所合作，檢驗治療通訊協定並展示功能性療效。這種實證基礎有助於與保險公司溝通，並為衛生經濟評估提供依據，而衛生經濟評估對於醫院採購委員會而言正變得日益重要。

為領導者提供具體建議，以協調產品設計、證據產生和商業策略，從而加速產品普及並建立強大的業務基礎。

產業領導企業可以採取以下幾個切實可行的步驟來強化其策略位置，並加速在所有醫療機構中的應用。首先，優先與臨床中心建立合作關係，共同製定通訊協定，並產生符合支付方要求的高品質結果數據。循證檢驗不僅對臨床醫生的接受至關重要，而且對報銷談判和採購核准也至關重要。其次，採用模組化產品架構，實現軟體的迭代改進，並允許選擇性地升級硬體。這有助於降低整體擁有成本 (TCO) 的擔憂，並有助於建立長期的客戶關係。

高度透明、多方面的調查方法結合了專家訪談、技術評估和證據的三角檢驗，為實際見解和分析提供了支持。

本執行摘要的調查方法整合了多方面的證據，以確保提供可靠且可操作的見解。主要研究包括對臨床醫生、復健專家、設備工程師和採購負責人進行結構化訪談，以收集關於可用性、臨床結果和採購標準的實際觀點。除這些定性資料外，還對設備架構、控制策略和材料進行了技術評估，以評估工程權衡和整合複雜性。

簡明扼要的結論強調了復健機器人技術的成熟以及將技術進步轉化為永續臨床影響所面臨的策略挑戰。

復健機器人技術在感測器、驅動技術和智慧控制技術的進步推動下，正日趨成熟，成為具有重要臨床意義和商業性價值的醫療技術領域。隨著設備變得更加便攜、穿戴式和方便用戶使用，其應用範圍正從住院患者擴展到門診病人和家庭環境。同時，不斷變化的價值鏈趨勢和報銷機制要求企業具備策略靈活性，因此，強調韌性和以結果為導向的價值提案至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 康復機器人市場：依產品類型分類

  • 治療訓練機器人
  • 輔助復健機器人
  • 外骨骼復健機器人
  • 用於評估和診斷的機器人
  • 陪伴型與社交復健機器人
  • 遠距復健機器人

第9章：康復機器人市場（依機器人設計分類）

  • 外骨骼機器人
  • 末端執行器機器人
  • 軟體機器人設備
  • 移動平台機器人
  • 固定式機器人工作站
  • 纜索驅動機器人系統

第10章：依身體部位分類的復健機器人市場

  • 上肢
    • 肩膀
    • 彎頭
    • 手腕
    • 手和手指
  • 下肢
    • 髖關節
    • 膝蓋
    • 腳踝和足部
  • 身體軀幹和核心
  • 全身

第11章 復健機器人市場：依應用領域分類

  • 老年人康復
  • 肌肉骨骼復健
  • 神經復健
  • 中風復健

第12章 康復機器人市場：依最終用戶分類

  • 居家照護
  • 醫院和診所
  • 復健中心
  • 研究機構

第13章 康復機器人市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 康復機器人市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 康復機器人市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國康復機器人市場

第17章：中國康復機器人市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AlterG, Inc.
  • Aretech, LLC
  • B-Temia Inc.
  • Bioness, Inc.
  • Bionik Laboratories Corp.
  • BioXtreme Ltd.
  • Cyberdyne Inc.
  • DIH Holding US, Inc.
  • Ekso Bionics Holdings, Inc.
  • Focal Meditech BV
  • Fourier Intelligence Group
  • GOGOA Mobility Robots, SL
  • Hocoma AG
  • Honda Motor Co., Ltd.
  • Instead Technologies, Ltd.
  • Kinova Inc.
  • KUKA AG
  • Leaders Rehab Robot
  • Life Science Robotics ApS
  • MediTouch Ltd.
  • Motorika USA Inc.
  • MRISAR
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • Rehab-Robotics Company Limited
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • Vincent Medical Holdings Limited
Product Code: MRR-02026C4CB0B9

The Rehabilitation Robots Market was valued at USD 575.05 million in 2025 and is projected to grow to USD 672.62 million in 2026, with a CAGR of 16.09%, reaching USD 1,634.19 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 575.05 million
Estimated Year [2026] USD 672.62 million
Forecast Year [2032] USD 1,634.19 million
CAGR (%) 16.09%

A concise introduction to the present state of rehabilitation robotics highlighting clinical adoption drivers, enabling technologies, and the shift to scalable patient-centered solutions

Rehabilitation robotics is at the intersection of medical science, engineering, and human-centered design, evolving from laboratory prototypes into clinically deployable tools that augment therapeutic pathways. Over the past decade, devices have moved beyond rigid, industrially inspired machines to more adaptive, sensor-rich systems that prioritize patient comfort, functional outcomes, and data-driven therapy personalization. This evolution reflects parallel advances in embedded sensors, actuator miniaturization, materials science, and machine learning algorithms capable of interpreting complex movement patterns.

Clinicians and health systems are increasingly interested in technologies that can extend the reach of scarce rehabilitation expertise, support intensive repeatable therapy sessions, and objectively measure progress. However, adoption is mediated by factors such as ease of integration into clinical workflows, the evidence base demonstrating functional gains, reimbursement frameworks, and device ergonomics. As a result, successful devices combine validated therapeutic protocols with intuitive user interfaces and robust safety features.

Looking ahead, the field is defined by a pragmatic shift: from proof-of-concept demonstrations toward scalable solutions that deliver measurable clinical value across inpatient, outpatient, and home-based settings. This transition is powered by cross-disciplinary collaboration among clinicians, engineers, and data scientists, and is supported by a maturing ecosystem of component suppliers, service partners, and regulatory pathways that together enable responsible clinical deployment.

An overview of the major transformative shifts driving the rehabilitation robotics landscape including AI integration, care decentralization, and resilient commercialization approaches

The rehabilitation robotics landscape is undergoing several transformative shifts that are reshaping product design, clinical use models, and business strategies. First, intelligence infusion is pervasive: embedded sensors, cloud-connected analytics, and adaptive control algorithms now enable devices to learn from patient-specific movement patterns and to modulate assistance in real time. This capability improves therapy personalization and creates opportunities for longitudinal outcome tracking.

Second, the locus of care is expanding beyond hospital walls into community clinics and the home. Advances in portability, battery technology, and simplified donning/dof mechanisms are enabling devices that clinicians and patients can use outside of supervised laboratory settings. Consequently, reimbursement and care-delivery models are adapting to emphasize remote monitoring, tele-rehabilitation support, and outcome-based payment arrangements.

Third, human factors and soft robotics are gaining prominence, with designers focusing on comfort, wearability, and naturalistic movement assistance rather than brute-force actuation. This emphasis reduces patient fatigue and improves adherence, particularly among geriatric and neurologic populations. In parallel, modular architectures that support hardware-software co-evolution are becoming common, allowing manufacturers to deploy iterative performance improvements without wholesale hardware replacement.

Finally, supply chain resilience and regulatory alignment are emerging as strategic imperatives. Manufacturers are investing in diversified sourcing, localized assembly, and stronger post-market surveillance capabilities to meet stringent safety expectations and to shorten time-to-clinical-deployment. Collectively, these shifts are converging to make rehabilitation robots more clinically relevant, commercially viable, and accessible across a broader range of care settings.

How the 2025 tariff environment reshaped supply chains, sourcing strategies, and commercial models for rehabilitation robotics across manufacturing and procurement

Changes in trade policy and tariff structures can materially affect manufacturers, component suppliers, and downstream purchasers of rehabilitation devices. The cumulative impact of United States tariffs enacted in 2025 has manifested across multiple operational vectors, including component sourcing, contract manufacturing economics, and pricing strategies. Suppliers reliant on imported actuators, precision sensors, or specialized polymers have faced increased input costs, which in turn pressured manufacturers to reassess sourcing footprints and product architecture choices.

In response to tariff-driven cost pressures, several original equipment manufacturers accelerated localization initiatives and strategic supplier diversification to mitigate exposure. These adjustments have included qualifying alternative vendors, redesigning assemblies to use more readily available components, and selectively onshoring higher-value production steps where labor and capital economics permitted. Such strategies helped preserve product performance while reducing vulnerability to trade policy volatility.

Procurement practices among large healthcare systems also shifted, as purchasing teams weighed total cost of ownership against device performance and support capabilities. Longer-term service agreements and multi-year maintenance contracts gained traction as ways to stabilize operating expenses despite unit price pressures. At the same time, some small and mid-sized suppliers encountered tighter margins, prompting consolidation activity and renewed focus on niche clinical applications where differentiated technology commands stronger pricing power.

From an innovation perspective, tariff-induced constraints spurred renewed emphasis on software-centric value propositions. Companies leaned into cloud analytics, remote therapy modules, and subscription-based service models to offset hardware cost headwinds. In short, the 2025 tariff environment accelerated structural changes in supply chains and commercial models, prompting a rebalancing toward resilience, modularity, and service-led differentiation.

Deep segmentation insights revealing how device architecture, therapeutic application, and end-user settings jointly determine clinical utility and commercialization pathways

Segment-level dynamics underscore where clinical need, device capability, and care delivery intersect to shape product strategy and commercialization. Based on device type, the universe includes End Effector Robots and Exoskeleton Robots. End Effector Robots are differentiated by stationary designs that anchor to a fixed platform and wearable variants that enable more natural, task-oriented exercises; each design path influences clinical workflows, portability, and rehabilitation task specificity. Exoskeleton Robots split into Full Body, Lower Limb, and Upper Limb categories, and these distinctions drive divergent engineering trade-offs in actuation complexity, control schemes, and patient fitting procedures.

Application-driven segmentation highlights therapeutic indications such as Geriatric Rehabilitation, Musculoskeletal Rehabilitation, Neurological Rehabilitation, and Stroke Rehabilitation. Devices tailored for geriatric rehabilitation prioritize safety, ease of use, and fall-mitigation features, while musculoskeletal solutions emphasize joint-level assistance and strength retraining. Neurological and stroke-focused technologies demand finer-grained control, adaptive assistance profiles, and validated outcome measures to support neuroplasticity-driven recovery.

End-user segmentation captures the diversity of deployment environments, spanning Home Care, Hospitals and Clinics, Rehabilitation Centers, and Research Institutes. Home care deployments require simplified setup, remote monitoring, and robust customer support. Hospitals and clinics demand seamless integration with existing therapy workflows and stringent infection control features. Rehabilitation centers favor devices that enable high-intensity, specialized protocols, and research institutes prioritize modularity and data access for experimental protocols. Understanding how device types map to applications and end users is essential for designing commercially viable propositions that align with clinical pathways and procurement norms.

Key regional insights into how demographic trends, healthcare funding models, and regulatory environments shape adoption trajectories across major global markets

Regional dynamics for rehabilitation robotics reflect differing demographic pressures, healthcare financing models, and regulatory environments. In the Americas, aging populations, concentrated healthcare networks, and established reimbursement systems have supported early adoption of both inpatient and outpatient robotic therapies. Healthcare providers in this region increasingly evaluate device investments against operational efficiencies and long-term rehabilitative outcomes, while private payers and public programs influence reimbursement design.

Europe, Middle East & Africa present a heterogeneous landscape where national regulatory frameworks, public healthcare funding, and clinical practice patterns vary widely. Western European health systems often emphasize evidence generation and cost-effectiveness studies, encouraging solutions that demonstrate clear functional gains. Meanwhile, some Middle Eastern and African markets prioritize acute care capabilities and may adopt innovative devices through centers of excellence or private specialty clinics, creating pockets of concentrated demand.

Asia-Pacific is characterized by rapid demographic shifts, expanding middle-class healthcare consumption, and strong government-led initiatives to modernize rehabilitation infrastructure. Several countries in the region are investing in digital health platforms and home-based care models, which create fertile conditions for wearable rehabilitation devices and remote therapy services. Across all regions, regulatory harmonization efforts and international clinical collaborations are smoothing pathways for cross-border device approval and multinational clinical trials, thereby accelerating global diffusion of validated solutions.

Insightful analysis of company strategies showing how clinical evidence, hardware-software integration, and service-led commercial models define competitive advantage

Competitive dynamics in rehabilitation robotics are defined by firms that combine clinical credibility with engineering excellence and go-to-market agility. Leading organizations invest heavily in clinical evidence generation, partnering with academic medical centers and rehabilitation clinics to validate therapeutic protocols and demonstrate functional outcomes. This evidence base supports engagement with payers and informs health economic assessments that are increasingly essential for hospital procurement committees.

Product strategies vary across the value chain. Some companies prioritize hardware differentiation-developing proprietary actuation systems, lightweight materials, and advanced sensing suites-while others focus on software ecosystems that enable remote monitoring, adaptive training programs, and clinician dashboards. A growing number of vendors emphasize interoperable platforms that can be upgraded via software, reducing the need for frequent hardware revisions and extending product lifecycles.

Commercially, successful firms blend direct clinical sales with channel partnerships and service-oriented revenue streams. They bolster adoption through training programs, clinician education, and outcomes-driven support offerings. Strategic alliances with component suppliers, contract manufacturers, and rehabilitation service providers also play an important role in scaling operations and accelerating geographic expansion. Overall, the competitive landscape rewards organizations that can demonstrate therapeutic benefit, deliver seamless clinical integration, and sustain post-sale support.

Actionable recommendations for leaders to align product design, evidence generation, and commercial strategies to accelerate adoption and build resilient operations

Industry leaders can take several practical actions to strengthen their strategic position and accelerate adoption across care settings. First, prioritize partnerships with clinical centers to co-develop protocols and generate high-quality outcome data that align with payer requirements. Evidence-based validation is critical not only for clinician acceptance but also for reimbursement discussions and procurement approvals. Second, pursue modular product architectures that enable iterative software improvements and allow selective hardware upgrades; this reduces total cost of ownership concerns and supports longer customer relationships.

Third, invest in supply-chain resilience by diversifying suppliers, qualifying secondary vendors, and considering localized assembly for critical subassemblies. Such measures mitigate trade-policy and logistics risks while improving lead-time predictability. Fourth, focus on the end-user experience-simplifying device setup, enhancing wearability, and designing clinician-facing interfaces that integrate with electronic health records-to lower barriers to clinical adoption and increase patient adherence.

Finally, develop hybrid commercial models that combine device sales with subscription-based services for analytics, clinician training, and remote monitoring. This approach creates recurring revenue, deepens customer relationships, and reinforces the clinical value proposition through continuous performance feedback. Taken together, these actions can help organizations navigate regulatory complexity, align with evolving care delivery models, and build sustainable competitive differentiation.

A transparent multi-method research methodology combining expert interviews, technical assessments, and evidence triangulation to underpin actionable insights and analysis

The research methodology underpinning this executive summary integrates multiple evidence streams to ensure robust, actionable insights. Primary research included structured interviews with clinicians, rehabilitation specialists, device engineers, and procurement professionals to capture frontline perspectives on usability, clinical outcomes, and purchasing criteria. These qualitative inputs were complemented by technical assessments of device architectures, control strategies, and materials to evaluate engineering trade-offs and integration complexity.

Secondary research drew on peer-reviewed clinical literature, regulatory filings, and publicly available technical specifications to triangulate claims about device performance and therapeutic mechanisms. Trade publications and conference proceedings provided contemporary examples of pilot deployments and early-stage clinical results. Data synthesis emphasized cross-validation among sources and critical appraisal of evidence quality.

Analytical rigor was maintained through a transparent triangulation process that reconciled qualitative insights with technical documentation and regulatory information. Limitations were explicitly acknowledged, including variability in clinical study designs and heterogeneity in deployment contexts. Where evidence gaps existed, recommendations were cautiously framed to reflect the range of plausible outcomes rather than definitive forecasts. This methodology ensures that conclusions are grounded in current practice and that strategic guidance remains practical for decision-makers.

A concise conclusion emphasizing the maturation of rehabilitation robotics and the strategic imperatives for translating technological advances into sustained clinical impact

Rehabilitation robotics is maturing into a clinically relevant and commercially viable segment of healthcare technology, driven by converging advances in sensors, actuation, and intelligent control. Adoption is expanding across inpatient, outpatient, and home settings as devices become more portable, wearable, and user-friendly. At the same time, supply-chain dynamics and evolving reimbursement frameworks require companies to be strategically nimble, emphasizing resilience and outcome-oriented value propositions.

Success in this evolving landscape depends on combining rigorous clinical validation with modular product design and robust commercial support. Firms that demonstrate clear therapeutic benefits, simplify clinical integration, and offer service-led business models will be well positioned to capture long-term adoption opportunities. Additionally, regional nuances in regulation, reimbursement, and care delivery will continue to influence deployment priorities and the pace of integration.

In sum, rehabilitation robotics stands at a pivotal moment where technological capability can translate into meaningful patient outcomes and new care paradigms, provided that stakeholders align around evidence generation, patient-centric design, and sustainable commercialization strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Rehabilitation Robots Market, by Product Type

  • 8.1. Therapeutic Training Robots
  • 8.2. Assistive Rehabilitation Robots
  • 8.3. Exoskeleton Rehabilitation Robots
  • 8.4. Assessment And Diagnostic Robots
  • 8.5. Companion And Social Rehabilitation Robots
  • 8.6. Tele-Rehabilitation Robots

9. Rehabilitation Robots Market, by Robot Design

  • 9.1. Exoskeleton Robots
  • 9.2. End-Effector Robots
  • 9.3. Soft Robotics Devices
  • 9.4. Mobile Platform Robots
  • 9.5. Stationary Robotic Workstations
  • 9.6. Cable-Driven Robotic Systems

10. Rehabilitation Robots Market, by Body Region

  • 10.1. Upper Limb
    • 10.1.1. Shoulder
    • 10.1.2. Elbow
    • 10.1.3. Wrist
    • 10.1.4. Hand And Fingers
  • 10.2. Lower Limb
    • 10.2.1. Hip
    • 10.2.2. Knee
    • 10.2.3. Ankle And Foot
  • 10.3. Trunk And Core
  • 10.4. Full Body

11. Rehabilitation Robots Market, by Application

  • 11.1. Geriatric Rehabilitation
  • 11.2. Musculoskeletal Rehabilitation
  • 11.3. Neurological Rehabilitation
  • 11.4. Stroke Rehabilitation

12. Rehabilitation Robots Market, by End User

  • 12.1. Home Care
  • 12.2. Hospitals Clinics
  • 12.3. Rehabilitation Centers
  • 12.4. Research Institutes

13. Rehabilitation Robots Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Rehabilitation Robots Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Rehabilitation Robots Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Rehabilitation Robots Market

17. China Rehabilitation Robots Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AlterG, Inc.
  • 18.6. Aretech, LLC
  • 18.7. B-Temia Inc.
  • 18.8. Bioness, Inc.
  • 18.9. Bionik Laboratories Corp.
  • 18.10. BioXtreme Ltd.
  • 18.11. Cyberdyne Inc.
  • 18.12. DIH Holding US, Inc.
  • 18.13. Ekso Bionics Holdings, Inc.
  • 18.14. Focal Meditech BV
  • 18.15. Fourier Intelligence Group
  • 18.16. GOGOA Mobility Robots, SL
  • 18.17. Hocoma AG
  • 18.18. Honda Motor Co., Ltd.
  • 18.19. Instead Technologies, Ltd.
  • 18.20. Kinova Inc.
  • 18.21. KUKA AG
  • 18.22. Leaders Rehab Robot
  • 18.23. Life Science Robotics ApS
  • 18.24. MediTouch Ltd.
  • 18.25. Motorika USA Inc.
  • 18.26. MRISAR
  • 18.27. Myomo, Inc.
  • 18.28. Ottobock SE & Co. KGaA
  • 18.29. Parker-Hannifin Corporation
  • 18.30. Rehab-Robotics Company Limited
  • 18.31. ReWalk Robotics Ltd.
  • 18.32. Rex Bionics Ltd.
  • 18.33. Tyromotion GmbH
  • 18.34. Vincent Medical Holdings Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL REHABILITATION ROBOTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL REHABILITATION ROBOTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY THERAPEUTIC TRAINING ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY THERAPEUTIC TRAINING ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY THERAPEUTIC TRAINING ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSISTIVE REHABILITATION ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSISTIVE REHABILITATION ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSISTIVE REHABILITATION ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON REHABILITATION ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON REHABILITATION ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON REHABILITATION ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSESSMENT AND DIAGNOSTIC ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSESSMENT AND DIAGNOSTIC ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSESSMENT AND DIAGNOSTIC ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COMPANION AND SOCIAL REHABILITATION ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COMPANION AND SOCIAL REHABILITATION ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COMPANION AND SOCIAL REHABILITATION ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TELE-REHABILITATION ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TELE-REHABILITATION ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TELE-REHABILITATION ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END-EFFECTOR ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END-EFFECTOR ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END-EFFECTOR ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SOFT ROBOTICS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SOFT ROBOTICS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SOFT ROBOTICS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MOBILE PLATFORM ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MOBILE PLATFORM ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MOBILE PLATFORM ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY ROBOTIC WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY ROBOTIC WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY ROBOTIC WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY CABLE-DRIVEN ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY CABLE-DRIVEN ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY CABLE-DRIVEN ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WRIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WRIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WRIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HAND AND FINGERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HAND AND FINGERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HAND AND FINGERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ANKLE AND FOOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ANKLE AND FOOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ANKLE AND FOOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TRUNK AND CORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TRUNK AND CORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TRUNK AND CORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GCC REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 179. GCC REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. GCC REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 181. GCC REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 182. GCC REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 203. G7 REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 205. G7 REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 206. G7 REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. NATO REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. NATO REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 211. NATO REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 213. NATO REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 214. NATO REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NATO REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)